214 related articles for article (PubMed ID: 29490071)
1. Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.
Bradbury AR; Patrick-Miller LJ; Egleston BL; Hall MJ; Domchek SM; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long JM; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS
J Natl Cancer Inst; 2018 Sep; 110(9):985-993. PubMed ID: 29490071
[TBL] [Abstract][Full Text] [Related]
2. Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study.
Beri N; Patrick-Miller LJ; Egleston BL; Hall MJ; Domchek SM; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long J; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS; Bradbury AR
Clin Genet; 2019 Feb; 95(2):293-301. PubMed ID: 30417332
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal follow-up after telephone disclosure in the randomized COGENT study.
Kilbride MK; Egleston BL; Hall MJ; Patrick-Miller LJ; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long JM; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS; Domchek SM; Bradbury AR
Genet Med; 2020 Aug; 22(8):1401-1406. PubMed ID: 32376981
[TBL] [Abstract][Full Text] [Related]
4. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
Patrick-Miller L; Egleston BL; Daly M; Stevens E; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Bradbury AR
Patient Educ Couns; 2013 Dec; 93(3):413-9. PubMed ID: 24075727
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
Jenkins J; Calzone KA; Dimond E; Liewehr DJ; Steinberg SM; Jourkiv O; Klein P; Soballe PW; Prindiville SA; Kirsch IR
Genet Med; 2007 Aug; 9(8):487-95. PubMed ID: 17700386
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.
Christensen KD; Uhlmann WR; Roberts JS; Linnenbringer E; Whitehouse PJ; Royal CDM; Obisesan TO; Cupples LA; Butson MB; Fasaye GA; Hiraki S; Chen CA; Siebert U; Cook-Deegan R; Green RC
Genet Med; 2018 Jan; 20(1):132-141. PubMed ID: 28726810
[TBL] [Abstract][Full Text] [Related]
7. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
[TBL] [Abstract][Full Text] [Related]
8. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
9. Web Platform vs In-Person Genetic Counselor for Return of Carrier Results From Exome Sequencing: A Randomized Clinical Trial.
Biesecker BB; Lewis KL; Umstead KL; Johnston JJ; Turbitt E; Fishler KP; Patton JH; Miller IM; Heidlebaugh AR; Biesecker LG
JAMA Intern Med; 2018 Mar; 178(3):338-346. PubMed ID: 29356820
[TBL] [Abstract][Full Text] [Related]
10. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD
J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848
[TBL] [Abstract][Full Text] [Related]
11. Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.
Interrante MK; Segal H; Peshkin BN; Valdimarsdottir HB; Nusbaum R; Similuk M; DeMarco T; Hooker G; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Heinzmann J; Kinney AY; Schwartz MD
JNCI Cancer Spectr; 2017 Sep; 1(1):pkx002. PubMed ID: 31304457
[TBL] [Abstract][Full Text] [Related]
12. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.
Green RC; Christensen KD; Cupples LA; Relkin NR; Whitehouse PJ; Royal CD; Obisesan TO; Cook-Deegan R; Linnenbringer E; Butson MB; Fasaye GA; Levinson E; Roberts JS;
Alzheimers Dement; 2015 Oct; 11(10):1222-30. PubMed ID: 25499536
[TBL] [Abstract][Full Text] [Related]
13. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
Loeb S; Keith SW; Cheng HH; Leader AE; Gross L; Sanchez Nolasco T; Byrne N; Hartman R; Brown LH; Pieczonka CM; Gomella LG; Kelly WK; Lallas CD; Handley N; Mille PJ; Mark JR; Brown GA; Chopra S; McClellan A; Wise DR; Hollifield L; Giri VN
JCO Precis Oncol; 2024 Mar; 8():e2300552. PubMed ID: 38452310
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients.
Bradbury AR; Egleston BL; Patrick-Miller LJ; Rustgi N; Brandt A; Brower J; DiGiovanni L; Fetzer D; Berkelbach C; Long JM; Powers J; Stopfer JE; Domchek SM
Clin Genet; 2020 Apr; 97(4):601-609. PubMed ID: 32022897
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer.
McCuaig JM; Stockley TL; Ferguson SE; Vicus D; Brennenstuhl S; Ott K; Kim RH; Metcalfe KA
J Genet Couns; 2023 Apr; 32(2):503-513. PubMed ID: 36478486
[TBL] [Abstract][Full Text] [Related]
16. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
17. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.
Doughty Rice C; Ruschman JG; Martin LJ; Manders JB; Miller E
Fam Cancer; 2010 Jun; 9(2):203-12. PubMed ID: 20473602
[TBL] [Abstract][Full Text] [Related]
18. Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes.
Binion S; Sorgen LJ; Peshkin BN; Valdimarsdottir H; Isaacs C; Nusbaum R; Graves KD; DeMarco T; Wood M; McKinnon W; Garber J; McCormick S; Ladd MK; Schwartz MD
J Telemed Telecare; 2024 Feb; 30(2):334-343. PubMed ID: 34779303
[TBL] [Abstract][Full Text] [Related]
19. Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.
Swisher EM; Rayes N; Bowen D; Peterson CB; Norquist BM; Coffin T; Gavin K; Polinsky D; Crase J; Bakkum-Gamez JN; Blank SV; Munsell MF; Nebgen D; Fleming GF; Olopade OI; Law S; Zhou A; Levine DA; D'Andrea A; Lu KH
JAMA Oncol; 2023 Nov; 9(11):1547-1555. PubMed ID: 37707822
[TBL] [Abstract][Full Text] [Related]
20. Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone Study.
Hall MJ; Patrick-Miller LJ; Egleston BL; Domchek SM; Daly MB; Ganschow P; Grana G; Olopade OI; Fetzer D; Brandt A; Chambers R; Clark DF; Forman A; Gaber R; Gulden C; Horte J; Long JM; Lucas T; Madaan S; Mattie K; McKenna D; Montgomery S; Nielsen S; Powers J; Rainey K; Rybak C; Savage M; Seelaus C; Stoll J; Stopfer JE; Yao XS; Bradbury AR
JCO Precis Oncol; 2018; 2():. PubMed ID: 31819920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
